TrialAnnals of oncology : official journal of the European Society for Medical Oncology2013

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.

H Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.